Back
Cleveland-Cliffs 10K Form
Sell
34
CLF
Cleveland-Cliffs
Last Price:
$9.45
Seasonality Move:
7.34%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-25 | 10Q | CLF/Cleveland-Cliffs Quarterly |
2024-02-08 | 10K | CLF/Cleveland-Cliffs Annual |
2023-10-25 | 10Q | CLF/Cleveland-Cliffs Quarterly |
2023-07-26 | 10Q | CLF/Cleveland-Cliffs Quarterly |
2023-04-26 | 10Q | CLF/Cleveland-Cliffs Quarterly |
2023-02-14 | 10K | CLF/Cleveland-Cliffs Annual |
Receive CLF News And Ratings
See the #1 stock for the next 7 days that we like better than CLF
CLF Financial Statistics
Sales & Book Value
Annual Sales: | $22B |
---|---|
Cash Flow: | $-235M |
Price / Cash Flow: | 7.99 |
Annual Sales: | $14.64 |
Price / Book: | 0.68 |
Profitability
EPS (TTM): | -0.96580 |
---|---|
Net Income (TTM): | $-462M |
Gross Margin: | $1.4B |
Return on Equity: | -6.03% |
Return on Assets: | -2.67% |
Cleveland-Cliffs Earnings Forecast
Key Cleveland-Cliffs Financial Ratios
-
The Gross Profit Margin over the past 40 years for CLF is 6.32%.
-
The Selling, General & Administrative Expenses for CLF have been equal to 2.62% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 72.43% of Operating Income.
-
The Net Earning history of CLF is 1.81% of Total Revenues.
-
Per Share Earnings over the last 40 years have been positive in 22 years.
Cleveland-Cliffs Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Metals & Mining |
Sector: | Materials |
Current Symbol: | CLF |
CUSIP: | 185899 |
Website: | clevelandcliffs.com |
Debt
Debt-to-Equity Ratio: | 0.55 |
---|---|
Current Ratio: | 1.85 |
Quick Ratio: | 0.5 |
Price-to-Earnings
Trailing P/E Ratio: | 12.13 |
---|---|
Forward P/E Ratio: | 23.65 |
CLF Technical Analysis vs Fundamental Analysis
Sell
34
Cleveland-Cliffs (CLF)
is a Sell
Is Cleveland-Cliffs a Buy or a Sell?
-
Cleveland-Cliffs stock is rated a SellThe current Cleveland-Cliffs [CLF] share price is $9.46. The Score for CLF is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.